Table 3.
Cell Model | µM BPAa | Treatment Length (h) | Summary of Outcomes | Ref. |
---|---|---|---|---|
JEG-3 | 25 | 10 min, 30 min, 1, 2 | Effects on aromatase activity: YES | Nativelle-Serpentini et al. (2003) |
18 | Effects on aromatase activity: YES | |||
50 | 10 min | Effects on aromatase activity/mRNA: NO | ||
30 min, 1 | Effects on aromatase activity: NO | |||
2 | Effects on aromatase activity: YES | |||
18 | Effects on aromatase activity: YES | |||
100 | 10 min, 2 | Effects on aromatase activity: YES | ||
30 min, 1 | Effects on aromatase activity: NO | |||
18 | Effects on aromatase activity: YES | |||
BeWo | 0.1, 10, 50 | approximately 1 | Effects on measure of drug efflux: YES | Jin and Audus (2005) |
Microsomes @term | 500 | 15 min | Effects on aromatase activity: YES | Benachour et al. (2007) |
1° Cytotrophoblasts | 8.8×10−4, 8.8×10−3 | 24 | Effects on measure of apoptosis: NO, necrosis: YES, TNF-α mRNA: YES, TNF-α prot: NO | Benachour and Aris (2009) |
0.0876, 0.438 | Effects on measure of apoptosis: YES, necrosis: YES, TNF-α mRNA: YES, TNF-α prot: YES | |||
0.876 | Effects on measure of apoptosis: YES, necrosis: NO, TNF-α mRNA: NO, TNF-α prot: NO | |||
8.76, 87.6 | Effects on measure of apoptosis: YES, necrosis NO, TNF-α mRNA: NO, TNF-α prot: YES | |||
438, 876 | Effects on measure of apoptosis: YES, necrosis YES, TNF-α mRNA: NO, TNF-α prot: YES | |||
JEG-3 | 1 | 24 | Effects on aromatase mRNA/protein expression or promoter activity, aromatase activity: NO | Huang and Leung (2009) |
PL30 | Effect on aromatase mRNA: NO | |||
JEG-3 | 5 | Effects on aromatase mRNA/protein expression or promoter activity, aromatase activity: YES | ||
PL30 | Effect on aromatase mRNA: NO | |||
JEG-3 | 25 | Effects on aromatase mRNA/protein expression or promoter activity, aromatase activity: YES | ||
PL30 | Effect on aromatase mRNA: YES | |||
JEG-3 | 50 | Effects on aromatase mRNA/protein expression or promoter activity, aromatase activity: YES | ||
PL30 | Effect on aromatase mRNA: YES | |||
JEG-3, PL30 | 100 | Effects on aromatase mRNA/protein expression or promoter activity, aromatase activity: YES | ||
3A, HTR-8/Svneo | 1.095 | 6 days | Effects on miR-146a expression: NO | Avissar-Whiting et al. (2010) |
3A | 10.95 | Effects on miR-146a expression/survival after miR-146a overexpression: NO | ||
HTR-8/Svneo | Effects on miR-146a expression: NO | |||
3A | 109.51 | Effects on miR-146a and other miR expression: YES; altered survival after miR-146a overexpression: NO | ||
TCL-1 | Effects on miR expression: NO | |||
HTR-8/Svneo | Effects on miR-146a and other miR expression: YES | |||
JEG-3 | 1×10−3 | 24 | Effects on proliferation: NO (also in BeWo cells) | Morice et al. (2011) |
48 | Effects on viability or proliferation: NO (also in BeWo cells) | |||
0.01 | 24 | Effects on proliferation: NO (also in BeWo cells) | ||
48 | Effects on viability or proliferation: NO (also in BeWo cells) | |||
0.1 | 1 or 6? | Effects on mRNA of cell cycle-related genes: SOME | ||
8 | Effects on mRNA of an apoptosis-related gene: YES | |||
24 | Effects on proliferation: YES (NO in BeWo) | |||
48 | Effect on viability: NO, apoptosis: YES, proliferation: YES (NO in BeWo) | |||
1 | 1 or 6? | Effects on mRNA of cell cycle-related genes: SOME | ||
8 | Effects on mRNA of an apoptosis-related gene: YES | |||
24 | Effects on proliferation: YES (NO in BeWo)—potentially through Errγ | |||
48 | Effects on proliferation: YES (NO in BeWo), viability: NO, apoptosis: YES | |||
10 | 24 | Effects on proliferation: YES (NO in BeWo); | ||
48 | Effects on proliferation: YES (NO in BeWo), viability: NO | |||
100 | 48 | Effects on viability: YES | ||
JEG-3 | 1, 5 | 24 | Effects on CRH mRNA/protein expression and promoter activity: NO, upstream proteins: SOME | Huang and Leung (2012)b |
25 | Effects on CRH mRNA/protein expression and promoter activity: YES, upstream proteins: SOME | |||
50 | Effects on CRH mRNA/protein expression and promoter activity: YES, upstream proteins: YES | |||
1° Villi | 5×10−4 | 24 | Effect on β-hCG in media with/without BPA-conditioned decidualized stromal cells (DSCs): NO;Effect on proinflammatory cytokine MIF: YES—not if co-cultured with BPA-conditioned DSCs | Mannelli et al. (2014) |
48 | Effect on β-hCG in media with/without BPA-conditioned decidualized stromal cells (DSCs): NO | |||
BeWo | 0.01 | 48 | Effect on proliferation: NO, invasion into endometrial cells YES; invasion-related mRNA/prot: YES, DNA methylation-related mRNA/prot: SOME | Wang et al. (2015) |
0.1 | Effect on proliferation: NO | |||
1 | Effect on proliferation: YES, invasion into endometrial cells: YES; invasion-related mRNA/prot: YES, DNA methylation-related mRNA/prot: SOME | |||
10 | Effect on proliferation: YES, invasion-related prot: YES, DNA methylation-related mRNA/prot: SOME | |||
100 | Effect on proliferation: NO, invasion into endometrial cells: YES, invasion-related mRNA/prot: YES, DNA methylation-related mRNA/prot: YES | |||
1000 | Effect on proliferation: YES | |||
1° Trophoblasts | 0.438 | 24 | Effects on 11B-HSD2 activity, mRNA, prot: NO | Rajakumar et al. (2015) |
1.095, 2.19, 4.38 | 24 | Effects on 11B-HSD2 activity, mRNA, prot: YES | ||
8.76 | 3 | Effects on 11B-HSD2 activity, mRNA, prot: NO | ||
6, 12 | Effects on 11B-HSD2 activity, mRNA, prot: YES | |||
24 | Effects on 11B-HSD2 activity, mRNA, prot: YES Effects on nutrient transport- and hormone-related mRNA: YES |
|||
HTR-8/Svneo | 1×10−9 | 24, 48 | Effect on viability: NO, proliferation: NO, migration: NO, invasion: NO, DNA content: NO | Spagnoletti et al. (2015) |
72 | Effect on viability: NO, proliferation: NO, migration: NO, invasion: NO, DNA content: YES | |||
1×10−7 | 24, 48 | Effect on viability: NO, proliferation: NO, migration: NO, invasion: NO, DNA content: YES | ||
72 | Effect on viability: NO, proliferation: NO, migration: NO, invasion: YES, DNA content: YES | |||
1×10−5 | 24 | Effect on viability: NO, proliferation: NO, migration: NO, invasion: NO, DNA content: NO, interaction w/ HUVECs: NO | ||
48 | Effect on viability: NO, proliferation: NO, migration: YES, invasion: YES, DNA content: YES (not reversed by ICI), interaction w/ HUVECs: NO | |||
72 | Effect on viability: NO, proliferation: NO, migration: YES, invasion: YES, DNA content: YES; differentiation: NO, cell cycle-related protein: NO | |||
1×10−3 | 24 | Effect on viability: NO, proliferation: NO, migration: NO, invasion: NO, DNA content: NO | ||
48 | Effect on viability: NO, proliferation: NO, migration: YES, invasion: YES, DNA content: YES | |||
72 | Effect on viability: NO, proliferation: NO, migration: YES, invasion: YES, DNA content: YES; differentiation: YES, cell cycle-related protein: YES | |||
0.1 | 24 | Effect on viability: NO, proliferation: NO, migration: NO, invasion: NO, DNA content: NO | ||
48 | Effect on viability: NO, proliferation: NO, migration: YES, invasion: YES, DNA content: YES | |||
72 | Effect on viability: NO, proliferation: NO, migration: YES, invasion: YES, DNA content: YES; differentiation: YES, cell cycle-related protein: NO | |||
1° in first trimester | 1×10−3 | 24, 48 | Effects on chemical efflux-related protein: NO | Sieppi et al. (2016) |
1° at term | 24 | Effects on chemical efflux-related protein/mRNA: NO | ||
48 | Effects on chemical efflux-related protein: YES—partly reversed by ICI mRNA: NO | |||
1° in first trimester | 0.1 | 24, 48 | Effects on chemical efflux-related protein: NO | |
1° at term | 24 | Effects on chemical efflux-related protein: NO; mRNA: YES | ||
48 | Effects on chemical efflux-related protein/mRNA: NO | |||
JEG-3 | 0.01–500 | 24 | Effects on cytotoxicity at 138–218 μM: YES; ROS generation: YES; aromatase activity at IC50=71 μM: YES | Perez-Albaladejo et al. (2017) |
HTR-8/Svneo | 0.1 | 24 | Effects on migration: NO | Lan et al. (2017) |
1, 10, 50 | Effects on migration: YES | |||
0.1 | 48 | Effects on proliferation: NO, migration: YES; invasion-related proteins: NO; adhesion-related protein: YES (NO mRNA), mesenchymal proteins/mRNA: NO | ||
1 | Effects on proliferation: NO, migration: YES; invasion-related proteins: SOME; adhesion-related protein: YES (NO mRNA), mesenchymal proteins/mRNA: NO. Effects potentially through ERK signaling | |||
10, 50 | Effects on proliferation: NO, migration: YES; invasion-related proteins: YES; adhesion-related protein and mRNA: YES, mesenchymal proteins/mRNA: NO | |||
1° villi in first trimester | 50 | 48, 72 | Effects on migration: YES; adhesion-related protein: NO |
Doses from studies were converted to μM to facilitate comparison across studies.
Authors also reported increased binding of CRE at the CRH promoter and CREB phosphorylation by BPA, but quantified data were not presented to include in this dose-response table.